NCT06445361RecruitingNot Applicable
The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 1 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium
Ziekenhuis Oost-Limburg2 sites in 1 country138 target enrollmentStarted: July 1, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 138
- Locations
- 2
- Primary Endpoint
- Prevalence of fibrosis in T1DM
Study Overview
Brief Summary
To determine the prevalence of NAFLD in T1DM patients.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •≥ 18 years of age
- •Written informed consent obtained
Exclusion Criteria
- •Excessive alcohol use
- •Exclusion of other causes of liver disease and secondary causes of liver steatosis
Outcomes
Primary Outcomes
Prevalence of fibrosis in T1DM
Time Frame: During the intervention
To determine the prevalence of fibrosis in a cohort of T1DM patients followed at the Departments of Endocrinology in ZOL by means of the FibroScan® device with vibration controlled attenuation parameter (VCTE) measurements.
Prevalence of NAFLD in T1DM
Time Frame: During the intervention
To determine the prevalence of steatosis in a cohort of T1DM patients followed at the Departments of Endocrinology in ZOL by means of the FibroScan® device with controlled attenuation parameter (CAP) measurements.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Prevalence of NAFLD in T2DM PatientsNAFLDT2DFatty Liver, NonalcoholicType 2 DiabetesNCT06445335Ziekenhuis Oost-Limburg385
Unknown
Not Applicable
Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseGlycogen HepatopathyLiver DiseasesType 1 DiabetesNCT05054712Consorci Sanitari de l'Alt Penedès i Garraf250
Completed
Not Applicable
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver BiopsyFatty LiverNCT01100398Brooke Army Medical Center400
Active, not recruiting
Not Applicable
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesNonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, LiverCirrhosis, LiverType 1 DiabetesNCT04595474Joslin Diabetes Center533
Unknown
Not Applicable
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.Non Alcoholic Fatty LiverNCT04553796Assiut University150